Phase I/II Dose-Finding Study of Crizotinib (CRIZ) in Combination with Erlotinib (E) in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC)
Year: 2012
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center, Washington University in St. Louis, Seattle Cancer Care Alliance, University of Washington, The University of Texas at San Antonio Health Science Center, The Ohio State University, University of Alabama at Birmingham, Pfizer (Italy), Pfizer (United States), Hackensack University Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2999880920